ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 390,63
-0,54%
Dow Jones
41 938,45
0,00%
DAX
20 095,40
-0,62%
Brent Oil
79,985
-0,78%
Bitcoin
90 953,77
-3,74%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Fusion Antibodies Plc (FAB) Cours

Fusion Antibodies Plc

Fusion Antibodies Plc (FAB)

First Trust Multi Cap Value AlphaDEX Fund
9,00
-0,10
( -1,10% )
Mis à jour : 11:36:54
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
9,00
Prix Achat
8,70
Prix Vente
9,30
Volume échangé
945 021
8,35 Fourchette du Jour 9,00
2,90 Plage de 52 semaines 11,75
Cap du marché
8,583M
Clôture Veille
9,10
Ouverture
8,85
Dernière Transaction
20000
@
9.0885
(O)
Dernière heure de transaction
14:46:30
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 553 035
Actions en circulation
95 365 564
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,86
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
1,14M
Bénéfice net
-2,23M

À propos de Fusion Antibodies Plc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.fusionantibodies.com
Siège social
Belfast, Gbr
Fondé
-
Fusion Antibodies Plc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker FAB. Le dernier cours de clôture d'Fusion Antibodies était de 9,10p. Au cours de la dernière année, les actions de Fusion Antibodies ont été négociées dans une fourchette de prix de 2,90p à 11,75p.

Fusion Antibodies compte actuellement 95 365 564 actions en circulation. La capitalisation boursière d'Fusion Antibodies est de £8,68 million. Fusion Antibodies a un ratio cours/bénéfice (ratio PE) de -3.86.

FAB Dernières nouvelles

Plus de nouvelles

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

04 Décembre 2024
Alliance News

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

04 Décembre 2024
RNS Regulatory News

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

19 Novembre 2024
Alliance News

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

19 Novembre 2024
RNS Regulatory News

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024   16 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Director/PDMR Shareholding   Fusion Antibodies plc (AIM: FAB), specialists in...

16 Octobre 2024
RNS Regulatory News

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

16 Octobre 2024
RNS Regulatory News

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

08 Octobre 2024
Alliance News

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024     Fusion Antibodies plc ("Fusion" or the "Company")   Result of AGM   Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

08 Octobre 2024
RNS Regulatory News

Fusion Antibodies PLC AGM statement and trading update

Fusion Antibodies PLC 08 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

08 Octobre 2024
RNS Regulatory News

Fusion Antibodies PLC Block admission six monthly return

Fusion Antibodies PLC 02 October 2024   2 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Block admission six monthly return   Fusion Antibodies plc (AIM: FAB), specialists...

02 Octobre 2024
RNS Regulatory News
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.25-12.195121951210.2511.758.1536781409.46474802DE
42.5539.53488372096.4511.756.3520024788.68792246DE
124.8114.2857142864.211.753.8515530356.67905826DE
266.1210.3448275862.911.752.914543605.2108547DE
524.2589.47368421054.7511.752.912805894.72371635DE
156-101-91.81818181821101102.97452606.18575082DE
260-72-88.8888888889812502.946110010.84544147DE

FAB - Frequently Asked Questions (FAQ)

What is the current Fusion Antibodies share price?
The current share price of Fusion Antibodies is 9,00p
How many Fusion Antibodies shares are in issue?
Fusion Antibodies has 95 365 564 shares in issue
What is the market cap of Fusion Antibodies?
The market capitalisation of Fusion Antibodies is GBP 8,68M
What is the 1 year trading range for Fusion Antibodies share price?
Fusion Antibodies has traded in the range of 2,90p to 11,75p during the past year
What is the PE ratio of Fusion Antibodies?
The price to earnings ratio of Fusion Antibodies is -3,86
What is the cash to sales ratio of Fusion Antibodies?
The cash to sales ratio of Fusion Antibodies is 7,56
What is the reporting currency for Fusion Antibodies?
Fusion Antibodies reports financial results in GBP
What is the latest annual turnover for Fusion Antibodies?
The latest annual turnover of Fusion Antibodies is GBP 1,14M
What is the latest annual profit for Fusion Antibodies?
The latest annual profit of Fusion Antibodies is GBP -2,23M
What is the registered address of Fusion Antibodies?
The registered address for Fusion Antibodies is 1 SPRINGBANK ROAD, SPRINGBANK INDUSTRIAL ESTATE, DUNMURRY, BELFAST, BT17 0QL
What is the Fusion Antibodies website address?
The website address for Fusion Antibodies is www.fusionantibodies.com
Which industry sector does Fusion Antibodies operate in?
Fusion Antibodies operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BLUBlue Star Capital Plc
9,00p
(260,00%)
1,94M
BTCVinanz Limited
22,00p
(31,34%)
569,98k
RCGHRc365 Holding Plc
2,75p
(30,95%)
2,13M
BANKFiinu Plc
0,625p
(25,00%)
2,18M
TM1Technology Minerals Plc
0,15p
(25,00%)
24,73M
EYEEagle Eye Solutions Group Plc
355,00p
(-24,63%)
148,74k
NFXNuformix Plc
0,05p
(-16,67%)
94,64M
JWNGJaywing Plc
0,525p
(-16,00%)
625,19k
PYXPyx Resources Limited
1,60p
(-15,12%)
287,1k
SYMESupply@me Capital Plc
0,003p
(-14,29%)
128,83M
TRPTower Resources Plc
0,035p
(-11,39%)
1,35B
ORCPOracle Power Plc
0,018p
(-5,26%)
217,56M
MSMNMosman Oil And Gas Limited
0,0315p
(-4,55%)
144,78M
CPXCap-xx Limited
0,15p
(-7,69%)
133,94M
SYMESupply@me Capital Plc
0,003p
(-14,29%)
128,83M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
FAB
Fusion Antibodies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés